tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CNCE is currently covered by 3 analysts with an average price target of $10.31. This is a potential upside of $10.31 (0%) from yesterday's end of day stock price of $0.
Concert Pharmaceuticals's activity chart (see below) currently has 55 price targets and 41 ratings on display. The stock rating distribution of CNCE is 80% BUY and 20% HOLD.
Analysts average stock forecasts to be materialized ratio is 22.78% with an average time for these price targets to be met of 272.56 days.
Highest price target for CNCE is $8, Lowest price target is $4, average price target is $10.31.
Most recent stock forecast was given by STEPHEN KIM from EVERCORE on 20-Jan-2023. First documented stock forecast 08-Jul-2014.
Currently out of the existing stock ratings of CNCE, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
17
1 years 3 months 6 days ago
0/1 (0%)
$10.12 (147.09%)
Buy
25
1 years 3 months 7 days ago
0/6 (0%)
$18.01 (257.65%)
Buy
17
$8.63 (103.11%)
17
1 years 11 months 3 days ago
1/6 (16.67%)
$12.9 (314.63%)
115
Buy
15
2 years 5 months 14 days ago
0/1 (0%)
$7.49 (99.73%)
Buy
9
$0.63 (7.53%)
13
2 years 6 months 21 days ago
3/10 (30%)
$6.03 (203.03%)
392
What is CNCE (Concert Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CNCE (Concert Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CNCE (Concert Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CNCE (Concert Pharmaceuticals)?
Which analyst is the currently most bullish on CNCE (Concert Pharmaceuticals)?
Which analyst is the currently most reserved on CNCE (Concert Pharmaceuticals)?
